William L Seibel (William Seibel)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 14

Top Topics

Top Venues

Journal of cell science

International journal of molecular sciences

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Alexander William Thorman, James Reigle, Somchai Chutipongtanate, Juechen Yang, Behrouz Shamsaei, Marcin Pilarczyk, Mehdi Fazel-Najafabadi, Rafal Adamczak, Michal Kouril, Surbhi Bhatnagar, Sarah A Hummel, Wen Niu, Ardythe L Morrow, Maria F Czyzyk-Krzeska, Robert E McCullumsmith, William L Seibel, Nicolas Nassar, Yi Zheng, David A Hildeman, Mario Medvedovic, Andrew B Herr, Jaroslaw Meller
Accelerating drug discovery and repurposing by combining transcriptional signature connectivity with docking. Science advances 10 (35) (2024)
Stephanie J Bouley, Andrew V Grassetti, Robert J Allaway, Matthew D Wood, Helen W Hou, India R Burdon Dasbach, William L Seibel, Jimmy Wu, Scott A Gerber, Konstantin H Dragnev, James A Walker, Yolanda Sanchez
Chemical genetic screens reveal defective lysosomal trafficking as synthetic lethal with NF1 loss. Journal of cell science 137 (15) (2024)
Stephanie J Bouley, Andrew V Grassetti, Robert J Allaway, Matthew D Wood, Helen W Hou, India R Burdon Dasbach, William L Seibel, Jimmy Wu, Scott A Gerber, Konstantin H Dragnev, James A Walker, Yolanda Sanchez
Chemical genetic screens reveal defective lysosomal trafficking as synthetic lethal with NF1 loss. Journal of cell science (2024)
Stephanie J Bouley, Andrew V Grassetti, Robert J Allaway, Matthew D Wood, Helen W Hou, India R Burdon Dasbach, William L Seibel, Jimmy Wu, Scott A Gerber, Konstantin H Dragnev, James A Walker, Yolanda Sanchez
Chemical genetic screens reveal defective lysosomal trafficking as synthetic lethal with NF1 loss. Journal of cell science 137 (15) (2024)
Stephanie J Bouley, Andrew V Grassetti, Robert J Allaway, Matthew D Wood, Helen W Hou, India R Burdon Dasbach, William L Seibel, Jimmy Wu, Scott A Gerber, Konstantin H Dragnev, James A Walker, Yolanda Sanchez
Chemical genetic screens reveal defective lysosomal trafficking as synthetic lethal with NF1 loss. Journal of cell science 137 (15) (2024)
Stephanie J Bouley, Andrew V Grassetti, Robert J Allaway, Matthew D Wood, Helen W Hou, India R Burdon Dasbach, William L Seibel, Jimmy Wu, Scott A Gerber, Konstantin H Dragnev, James A Walker, Yolanda Sanchez
Chemical genetic screens reveal defective lysosomal trafficking as synthetic lethal with NF1 loss. Journal of cell science 137 (15) (2024)
Akhila Dandamudi, William L Seibel, Benjamin Tourdot, Jose A Cancelas, Huzoor Akbar, Yi Zheng
Structure-Activity Relationship Analysis of Rhosin, a RhoA GTPase Inhibitor, Reveals a New Class of Antiplatelet Agents. International journal of molecular sciences 24 (4) (2023)
Akhila Dandamudi, William L Seibel, Benjamin Tourdot, Jose A Cancelas, Huzoor Akbar, Yi Zheng
Structure-Activity Relationship Analysis of Rhosin, a RhoA GTPase Inhibitor, Reveals a New Class of Antiplatelet Agents. International journal of molecular sciences 24 (4) (2023)
Akhila Dandamudi, William L Seibel, Benjamin Tourdot, Jose A Cancelas, Huzoor Akbar, Yi Zheng
Structure-Activity Relationship Analysis of Rhosin, a RhoA GTPase Inhibitor, Reveals a New Class of Antiplatelet Agents. International journal of molecular sciences 24 (4) (2023)
Akhila Dandamudi, William L Seibel, Benjamin Tourdot, Jose A Cancelas, Huzoor Akbar, Yi Zheng
Structure-Activity Relationship Analysis of Rhosin, a RhoA GTPase Inhibitor, Reveals a New Class of Antiplatelet Agents. International journal of molecular sciences 24 (4) (2023)
Akhila Dandamudi, William L Seibel, Benjamin Tourdot, Jose A Cancelas, Huzoor Akbar, Yi Zheng
Structure-Activity Relationship Analysis of Rhosin, a RhoA GTPase Inhibitor, Reveals a New Class of Antiplatelet Agents. International journal of molecular sciences 24 (4) (2023)
Laura Barreyro, Avery M Sampson, Chiharu Ishikawa, Kathleen M Hueneman, Kwangmin Choi, Mario A Pujato, Somchai Chutipongtanate, Michael Wyder, Wendy D Haffey, Eric O'Brien, Mark Wunderlich, Vighnesh Ramesh, Ellen K Gagliani, Cem Meydan, Yaseswini Neelamraju, Lyndsey C Bolanos, Susanne Christie, Molly A Smith, Madeline Niederkorn, Tomoya Muto, Santosh Kesari, Francine E Garrett-Bakelman, Boris Bartholdy, Britta Will, Matthew T Weirauch, James C Mulloy, Zartash Gul, Stephen Medlin, Rhett A Kovall, Ari M Melnick, John P Perentesis, Kenneth D Greis, Elmar Nurmemmedov, William L Seibel, Daniel T Starczynowski
Blocking UBE2N abrogates oncogenic immune signaling in acute myeloid leukemia. Science translational medicine 14 (635) (2022)
Mohammad Azhar, Zachary Kincaid, Meenu Kesarwani, Jacob Menke, Joshua Sweiterman, Sekhu Ansari, Angela Reaves, Arhama Ahmed, Rammsha Shahzad, Areeba Khan, Nuha Syed, Noor Amir, Mark Wunderlich, Tahir Latif, William L Seibel, Mohammad Azam
Rational polypharmacological targeting of FLT3, JAK2, ABL, and ERK1 suppresses the adaptive resistance to FLT3 inhibitors in AML. Blood advances (2022)
Shailaja Hegde, Anjelika Gasilina, Mark Wunderlich, Yuan Lin, Marcel Buchholzer, Oliver H F Krumbach, Mohammad Akbarzadeh, Mohammad Reza Ahmadian, William L Seibel, Yi Zheng, John P Perentesis, Benjamin E Mizukawa, Lisa Privette Vinnedge, José A Cancelas, Nicolas N Nassar
Inhibition of the RacGEF VAV3 by the small molecule IODVA1 impedes RAC signaling and overcomes resistance to tyrosine kinase inhibition in acute lymphoblastic leukemia. Leukemia (2021)